MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20253669

March 18, 2025

Drug Information

利伐沙班片

片剂

2.5mg

化学药品

March 18, 2025

Company Information

Applicant Company

北京市北京经济技术开发区荣京东街7号

Manufacturing Company

北京市北京经济技术开发区荣京东街7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath